Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Linde PLC (LIN) vs UnitedHealth Group Inc (UNH) Price & Performance

Linde PLCTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Linde PLC vs UnitedHealth Group Inc — how do they compare? Linde PLC trades at $506.77 (market cap $236.74B), while UnitedHealth Group Inc trades at $434.5 (market cap $382.83B). The key difference: UnitedHealth Group Inc is the larger of the two by market cap, and UnitedHealth Group Inc pays the higher dividend (2.2%). Which is the better fit depends on your goals.

LINUNH
Market Cap
$236.74B$382.83B
Sector
Basic MaterialsHealth
52-Week High
$546.64$431.68
52-Week Low
$389.38$237.77
Enterprise Value
$259.10B$429.52B
Dividend Yield
1.25%2.2%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Linde PLC

Linde (LIN) trades at $513.07, down 1.47% today, with strong fundamentals including 20.44% net income margin and consistent earnings beats. Technical indicators show a bearish trend with support at $509 and resistance at $520. The company maintains robust cash flow from operations of $10.35B and has raised dividends, reflecting financial health.

Outlook remains positive with 89% analyst buy ratings and a $564.80 price target, though valuation ratios are elevated. Risks include rising debt-to-asset ratio (31.63% in 2025) and potential macroeconomic pressures. The stock offers growth potential but requires monitoring of leverage and market conditions.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $426.09, up 0.64% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations of $4.94. Revenue growth remains robust, reaching $447.57 billion in 2025, though net margins have compressed to 2.68%. Recent corporate actions include a $2.32 dividend and ongoing share repurchases, while news highlights operational streamlining like reduced pediatric prior authorizations.

UNH's outlook is positive, driven by aging demographics and tech innovation in healthcare, offering upside to the $467.12 consensus target. Risks include regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. Institutional sentiment is strongly bullish, with 82.69% of analysts rating it a buy, supporting long-term growth prospects amid sector tailwinds.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Linde PLC

Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $31 billion in revenue and $5 billion in GAAP operating profit in 2021.

Read more on LIN

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH